Teligene Funding: $93M Raised, Investors & Rounds

Teligene funding overview

Teligene is based in Suzhou, China. Teligene has raised $93M in total disclosed funding. That places its disclosed total in the $25M–$100M range. The round record for Teligene runs through 2021; nothing later has been disclosed. Investors on record include Suzhong Pharma, China Construction Bank, GTJA Investment Group, CCB Capital, IDG Capital, Shenzhen Capital and 2 others. 8 distinct backers are named across the disclosed rounds.

Teligene at a glance

Total raised: $93M
Latest round date: February 2021
Headquarters: Suzhou, China
Notable investors: Suzhong Pharma, China Construction Bank, GTJA Investment Group, CCB Capital, IDG Capital, Shenzhen Capital, Loyal Valley Capital, Huitianfu Capital

Frequently asked about Teligene funding

How much has Teligene raised?: Teligene has raised $93M in total disclosed funding across the rounds on record.
Who has invested in Teligene?: Suzhong Pharma, China Construction Bank, GTJA Investment Group, CCB Capital, IDG Capital, Shenzhen Capital are named among the investors backing Teligene.
What was the latest Teligene funding round?: No round stage has been disclosed for Teligene.
Where is Teligene based?: Teligene is based in Suzhou, China.
When did Teligene last raise?: The last disclosed Teligene round closed in February 2021.

Round data for Teligene is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Suzhou and backer lists below.

Teligene Funding: $93M Raised, Investors & Rounds

Teligene funding overview

Teligene at a glance

Frequently asked about Teligene funding

Companies related to Teligene (18)

Browse related funding lists (3)